Regeneron Pharmaceuticals (REGN) stock forecast for 2026
Last update: 08-15-2022, 5:51
Sector: HealthcareThe share price of Regeneron Pharmaceuticals, Inc. (REGN) now
What analysts predict:: $685.7
52-week high/low: $747.42 / $538.01
50/200 Day Moving Average: $597.55 / $634.48
This figure corresponds to the average price over the previous 50/200 days. For Regeneron Pharmaceuticals stocks, the 50-day moving average is the support level today.
For Regeneron Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in Regeneron Pharmaceuticals stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Regeneron Pharmaceuticals stock price in 2026. How much will one Regeneron Pharmaceuticals share be worth in 2026?
Is it worth taking profit / loss on Regeneron Pharmaceuticals stock now or waiting? What are analysts' forecasts for Regeneron Pharmaceuticals stock?
We forecast Regeneron Pharmaceuticals stock performance using neural networks based on historical data on Regeneron Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Regeneron Pharmaceuticals stock prediction results are shown below and presented as a graph, table and text information.
Regeneron Pharmaceuticals stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Regeneron Pharmaceuticals analysts is $685.7.
Today 200 Day Moving Average is the resistance level (634.48 $).
50 Day Moving Average is the support level (597.55 $).
Historical and forecast chart of Regeneron Pharmaceuticals stock
The chart below shows the historical price of Regeneron Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Regeneron Pharmaceuticals stock price can be found in the table below.
Regeneron Pharmaceuticals (REGN) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1 294.86 | 1 263.39 | 1 383.43 | 8.68 % |
| Feb | 1 289.03 | 1 243.79 | 1 376.04 | 9.61 % |
| Mar | 1 272.79 | 1 248.73 | 1 338.08 | 6.68 % |
| Apr | 1 334.65 | 1 273.39 | 1 427.14 | 10.77 % |
| May | 1 399.51 | 1 369.28 | 1 482.64 | 7.65 % |
| Jun | 1 340.31 | 1 255.87 | 1 410.27 | 10.95 % |
| Jul | 1 429.58 | 1 378.11 | 1 527.36 | 9.77 % |
| Aug | 1 501.63 | 1 461.08 | 1 608.39 | 9.16 % |
| Sep | 1 623.26 | 1 553.13 | 1 684.62 | 7.81 % |
| Oct | 1 741.59 | 1 633.44 | 1 827.80 | 10.63 % |
| Nov | 1 876.39 | 1 840.93 | 1 991.23 | 7.55 % |
| Dec | 1 891.59 | 1 808.17 | 1 975.01 | 8.45 % |
Regeneron Pharmaceuticals information and performance
Regeneron Pharmaceuticals, Inc. is an American biotech company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Initially, it focused on neurotrophic factors and their regenerative capabilities (hence the name), and then branched out into the study of both cytokine and tyrosine kinase receptors.
Regeneron Pharmaceuticals Address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, US
Market Capitalization: 68 534 424 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 7 376 800 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 12.94
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 9.27
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: 48.6
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: -0.733
Quarterly Revenue Growth YOY: -0.444
Trailing PE: 12.94
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 15.53
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 4.573
Enterprise Value (EV) /Revenue
EV To EBITDA: 9.72
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 107190000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Regeneron Pharmaceuticals price target for 2021 by month
Target values for the price of one Regeneron Pharmaceuticals share for Jan 2026.
Pessimistic target level: 1 263.39
Optimistic target level: 1 383.43
Target values for the price of one Regeneron Pharmaceuticals share for Feb 2026.
Pessimistic target level: 1 243.79
Optimistic target level: 1 376.04
Target values for the price of one Regeneron Pharmaceuticals share for Mar 2026.
Pessimistic target level: 1 248.73
Optimistic target level: 1 338.08
Target values for the price of one Regeneron Pharmaceuticals share for Apr 2026.
Pessimistic target level: 1 273.39
Optimistic target level: 1 427.14
Target values for the price of one Regeneron Pharmaceuticals share for May 2026.
Pessimistic target level: 1 369.28
Optimistic target level: 1 482.64
Target values for the price of one Regeneron Pharmaceuticals share for Jun 2026.
Pessimistic target level: 1 255.87
Optimistic target level: 1 410.27
Target values for the price of one Regeneron Pharmaceuticals share for Jul 2026.
Pessimistic target level: 1 378.11
Optimistic target level: 1 527.36
Target values for the price of one Regeneron Pharmaceuticals share for Aug 2026.
Pessimistic target level: 1 461.08
Optimistic target level: 1 608.39
Target values for the price of one Regeneron Pharmaceuticals share for Sep 2026.
Pessimistic target level: 1 553.13
Optimistic target level: 1 684.62
Target values for the price of one Regeneron Pharmaceuticals share for Oct 2026.
Pessimistic target level: 1 633.44
Optimistic target level: 1 827.80
Target values for the price of one Regeneron Pharmaceuticals share for Nov 2026.
Pessimistic target level: 1 840.93
Optimistic target level: 1 991.23
Target values for the price of one Regeneron Pharmaceuticals share for Dec 2026.
Pessimistic target level: 1 808.17
Optimistic target level: 1 975.01
